CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses KE Lineburg, EJ Grant, S Swaminathan, DSM Chatzileontiadou, C Szeto, ... Immunity 54 (5), 1055-1065. e5, 2021 | 163 | 2021 |
TCR recognition of peptide–MHC-I: Rule makers and breakers C Szeto, CA Lobos, AT Nguyen, S Gras International journal of molecular sciences 22 (1), 68, 2020 | 127 | 2020 |
Canonical T cell receptor docking on peptide–MHC is essential for T cell signaling P Zareie, C Szeto, C Farenc, SD Gunasinghe, EM Kolawole, A Nguyen, ... Science 372 (6546), eabe9124, 2021 | 72 | 2021 |
The pockets guide to HLA class I molecules AT Nguyen, C Szeto, S Gras Biochemical Society Transactions 49 (5), 2319-2331, 2021 | 62 | 2021 |
Contribution of the first K-homology domain of poly (C)-binding protein 1 to its affinity and specificity for C-rich oligonucleotides YMK Yoga, DAK Traore, M Sidiqi, C Szeto, NR Pendini, A Barker, ... Nucleic acids research 40 (11), 5101-5114, 2012 | 56 | 2012 |
The unconventional role of HLA-E: The road less traveled EJ Grant, AT Nguyen, CA Lobos, C Szeto, DSM Chatzileontiadou, S Gras Molecular immunology 120, 101-112, 2020 | 45 | 2020 |
CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph L Hensen, PT Illing, E Bridie Clemens, THO Nguyen, M Koutsakos, ... Nature communications 12 (1), 2931, 2021 | 25 | 2021 |
Protein purification and crystallization of HLA-A∗ 02: 01 in complex with SARS-CoV-2 peptides DSM Chatzileontiadou, C Szeto, D Jayasinghe, S Gras STAR protocols 2 (3), 100635, 2021 | 20 | 2021 |
The presentation of SARS-CoV-2 peptides by the common HLA-A∗ 02: 01 molecule C Szeto, DSM Chatzileontiadou, AT Nguyen, H Sloane, CA Lobos, ... Iscience 24 (2), 2021 | 20 | 2021 |
HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people JR Habel, AT Nguyen, LC Rowntree, C Szeto, NA Mifsud, EB Clemens, ... PLoS pathogens 18 (3), e1010337, 2022 | 19 | 2022 |
Molecular basis of a dominant SARS-CoV-2 spike-derived epitope presented by HLA-A* 02: 01 recognised by a public TCR C Szeto, AT Nguyen, CA Lobos, DSM Chatzileontiadou, D Jayasinghe, ... Cells 10 (10), 2646, 2021 | 19 | 2021 |
Impact of HLA-DR antigen binding cleft rigidity on T cell recognition C Szeto, JI Bloom, H Sloane, CA Lobos, J Fodor, D Jayasinghe, ... International journal of molecular sciences 21 (19), 7081, 2020 | 11 | 2020 |
Covalent TCR-peptide-MHC interactions induce T cell activation and redirect T cell fate in the thymus C Szeto, P Zareie, RC Wirasinha, JB Zhang, AT Nguyen, ... Nature Communications 13 (1), 4951, 2022 | 10 | 2022 |
Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan CE van de Sandt, THO Nguyen, NA Gherardin, JC Crawford, J Samir, ... Nature immunology 24 (11), 1890-1907, 2023 | 9 | 2023 |
Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross‐reactive potential AT Nguyen, HMP Lau, H Sloane, D Jayasinghe, NA Mifsud, ... Clinical & Translational Immunology 11 (10), e1422, 2022 | 9 | 2022 |
SARS-cov-2 spike-derived peptides presented by HLA molecules AT Nguyen, C Szeto, D Jayasinghe, CA Lobos, H Halim, ... Biophysica 1 (2), 194-203, 2021 | 7 | 2021 |
Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection L Cooper, H Xu, J Polmear, L Kealy, C Szeto, ES Pang, M Gupta, A Kirn, ... Immunity 57 (5), 1037-1055. e6, 2024 | 5 | 2024 |
Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3 S Swaminathan, KE Lineburg, A Panikkar, J Raju, LD Murdolo, C Szeto, ... Nature Communications 13 (1), 6387, 2022 | 5 | 2022 |
COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals AT Nguyen, C Szeto, DSM Chatzileontiadou, ZWM Tong, MJ Dewar-Oldis, ... bioRxiv, 2022.01. 12.473243, 2022 | 4 | 2022 |
Pre-existing cellular immunity to SARS-CoV-2 through an immunodominant epitope KE Lineburg, EJ Grant, S Swaminathan, DSM Chatzileontiadou, C Szeto, ... | 3 | 2021 |